Is KPV legal? FDA status and US regulatory standing
Current status
Compounding nomination withdrawn. KPV was nominated for the FDA bulk drug substances compounding list and was previously placed in a safety-review category before the nomination was withdrawn, so it does not appear on the current bulk substances lists.
Primary source: www.fda.gov
Federal legal status
FDA approval status
KPV was nominated for the FDA bulk drug substances compounding list and was previously placed in a safety-review category before the nomination was withdrawn, so it does not appear on the current bulk substances lists. Alpha-MSH C-terminal tripeptide fragment (Lys-Pro-Val). Anti-inflammatory. No FDA approval, no NDA or IND. Not on any FDA list. Research chemical only.
Also known as
Lys-Pro-Val · alpha-MSH tripeptide
Frequently asked questions
- Is KPV FDA approved?
- KPV was nominated for the FDA bulk drug substances compounding list and was previously placed in a safety-review category before the nomination was withdrawn, so it does not appear on the current bulk substances lists. Primary source linked on this page.
- Is KPV legal to buy?
- KPV is available in the U.S. as a research-use-only compound. It was nominated for the FDA bulk drug substances compounding list and was previously placed in a safety-review category before the nomination was withdrawn, so it does not appear on the current bulk substances lists. Sale for human consumption is not permitted.
Content review: Regulatory status is sourced from the linked primary records and reviewed by the PeptideBase editorial team. This page is educational — not legal or medical advice. Last reviewed: .